Performance analysis of Atara Biotherapeutics (ATRA)
Annual Return
Over the past 3 years, ATRA has had an average annual return of -36.45%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, ATRA has had an average annual return of -50.46%, underperforming the benchmark SPY, which returned +14.05% annual.
Over the past 10 years, ATRA has had an average annual return of -31.80%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Oct 16, 2014, ATRA has had an average annual return of -24.64%, underperforming the benchmark SPY, which returned +14.75% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -45.21% | +35.80% | +3.73% | -84.35% | -79.19% | -19.72% | +19.19% | -52.59% | +91.94% | +27.47% | -46.23% | -1.27% |
| 2014 | |||||||||||
| +151.17% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -71.28% | +4.62% | -12.75% | +0.56% | +120.67% | -5.82% | -45.21% | ||||||
| 2025 | -33.20% | -22.16% | -14.23% | +34.53% | -2.33% | -1.02% | +49.31% | +4.62% | +18.76% | +3.72% | +1.61% | +19.75% | +35.80% |
| 2024 | +21.58% | +24.74% | -10.81% | -0.61% | -18.67% | -39.47% | +15.67% | -22.76% | +7.02% | +9.84% | +36.42% | +9.41% | +3.73% |
| 2023 | +54.58% | -20.12% | -28.40% | -6.54% | -43.54% | +5.22% | +37.24% | -33.93% | +1.39% | -12.88% | -48.80% | -22.26% | -84.35% |
| 2022 | -2.53% | -16.34% | -27.71% | -31.54% | -18.24% | +49.81% | -61.11% | +32.34% | -5.74% | +23.30% | -2.79% | -27.60% | -79.19% |
| 2021 | -5.96% | -9.10% | -14.42% | -2.09% | -3.56% | +14.68% | -18.01% | +17.49% | +19.49% | -13.52% | +15.57% | -11.91% | -19.72% |
| 2020 | -19.67% | -8.17% | -29.95% | -2.59% | +38.72% | +26.70% | -14.96% | +8.79% | -3.86% | -0.39% | +79.63% | -15.35% | +19.19% |
| 2019 | +9.38% | -5.76% | +11% | -15.47% | -33.90% | -9.45% | -29.04% | -5.40% | +4.59% | -22.66% | +30.12% | +15.90% | -52.59% |
| 2018 | +108.84% | +1.92% | +1.23% | +3.46% | +23.42% | -26.21% | +2.18% | +9.06% | +0.98% | -17.36% | +16.91% | -13.04% | +91.94% |
| 2017 | -5.28% | +14.87% | +33.01% | -16.79% | -22.51% | +5.67% | +8.92% | +3.28% | +5.08% | -14.20% | +1.76% | +25.26% | +27.47% |
Drawdown analysis of Atara Biotherapeutics (ATRA)
The maximum drawdown for the ATRA was -99.74%, occurring on Feb 20, 2026. This drawdown has not yet recovered.
The current ATRA drawdown is -99.38%.
Since Oct 16, 2014 ATRA has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 3 times
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.74% | Apr 23, 2015 | 2723 | Feb 20, 2026 | Ongoing | Ongoing | Ongoing |
| -43.40% | Dec 2, 2014 | 50 | Feb 13, 2015 | 18 | Mar 12, 2015 | 68 |
| -21.56% | Nov 7, 2014 | 3 | Nov 12, 2014 | 13 | Dec 2, 2014 | 16 |
| -10.42% | Mar 23, 2015 | 3 | Mar 26, 2015 | 2 | Mar 30, 2015 | 5 |
| -7.46% | Oct 20, 2014 | 3 | Oct 23, 2014 | 1 | Oct 24, 2014 | 4 |
| -7.11% | Oct 28, 2014 | 1 | Oct 29, 2014 | 3 | Nov 3, 2014 | 4 |
| -6.34% | Mar 30, 2015 | 2 | Apr 1, 2015 | 1 | Apr 2, 2015 | 3 |
| -5.14% | Mar 12, 2015 | 1 | Mar 13, 2015 | 2 | Mar 17, 2015 | 3 |
| -4.65% | Mar 17, 2015 | 1 | Mar 18, 2015 | 1 | Mar 19, 2015 | 2 |
| -3.50% | Apr 2, 2015 | 1 | Apr 6, 2015 | 2 | Apr 8, 2015 | 3 |
| -1.95% | Apr 16, 2015 | 1 | Apr 17, 2015 | 1 | Apr 20, 2015 | 2 |
| -0.44% | Nov 5, 2014 | 1 | Nov 6, 2014 | 1 | Nov 7, 2014 | 2 |
| -0.27% | Apr 13, 2015 | 2 | Apr 15, 2015 | 1 | Apr 16, 2015 | 3 |